Canntab Therapeutics is a biopharmaceutical company that aims at manufacturing & distributing hard pill cannabinoid formulations.
Canntab Therapeutics has raised $1.0M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in February 2022.
Canntab Therapeutics is headquartered in Markham, Canada.
Canntab Therapeutics is a biopharmaceutical company that aims at manufacturing & distributing hard pill cannabinoid formulations.
Canntab Therapeutics is at the Post-IPO Debt stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Canntab Therapeutics — Funding & Investors." VCBacked, February 1, 2022, https://www.vcbacked.co/company/canntab-therapeutics. Accessed August 13, 2026.
VCBacked. (2022). Canntab Therapeutics — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/canntab-therapeutics
{{cite web |title=Canntab Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/canntab-therapeutics |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated